Comparison of high-specific-activity ultratrace 123/131I-MIBG and carrier-added 123/131I-MIBG on efficacy, pharmacokinetics, and tissue distribution

John A Barrett, John L Joyal, Shawn M Hillier, Kevin P Maresca, Frank J Femia, James F Kronauge, Marie Boyd, Robert J Mairs, John W Babich

Research output: Contribution to journal › Article › peer-review

69 Citations (Scopus)

302 Downloads (Pure)

Filter

2012
The use of targeted radionuclide therapy for the treatment of malignant melanoma in vivo
Joyce, C., Boyd, M., Sorensen, A., Tesson, M., Babich, J. W. & Mairs, R. J., Jan 2012, In: Mutagenesis. 27, 1, p. 110-110 1 p.
Research output: Contribution to journal › Conference Contribution › peer-review
Activation of the noradrenaline transporter gene using the radiation-inducible WAF1-1 promoter sensitizes tumour cells to [I-131] MIBG targeted radiotherapy
McCluskey, A. G., Mairs, R. J., Robson, T., Hirst, D. G. & Boyd, M., 2012, In: Mutagenesis. 27, 1, p. 131-131 1 p., 82.
Research output: Contribution to journal › Conference Contribution › peer-review
Efficacy in vivo of a cancer therapy strategy combining HSV1716 mediated oncolysis with gene transfer and targeted radiotherapy
Sorensen, A., Mairs, R. J., Braidwood, L., Joyce, C., Conner, J., Pimlott, S., Brown, S. M. & Boyd, M., 2012, In: Mutagenesis. 27, 1, p. 134-135 2 p.
Research output: Contribution to journal › Conference Contribution › peer-review

Research output